File Download

There are no files associated with this item.

Supplementary

Conference Paper: Sodium-glucose cotransporter-2 inhibitors were associated with lower risk of colorectal cancer and adenoma than metformin in patients with type 2 diabetes mellitus.

TitleSodium-glucose cotransporter-2 inhibitors were associated with lower risk of colorectal cancer and adenoma than metformin in patients with type 2 diabetes mellitus.
Authors
Cheung, KSMao, XTan, JTLeung, WKSeto, WK
Issue Date13-Oct-2024
Persistent Identifierhttp://hdl.handle.net/10722/354483

 

DC FieldValueLanguage
dc.contributor.authorCheung, KS-
dc.contributor.authorMao, X-
dc.contributor.authorTan, JT-
dc.contributor.authorLeung, WK-
dc.contributor.authorSeto, WK-
dc.date.accessioned2025-02-09T00:35:15Z-
dc.date.available2025-02-09T00:35:15Z-
dc.date.issued2024-10-13-
dc.identifier.urihttp://hdl.handle.net/10722/354483-
dc.languageeng-
dc.relation.ispartofUnited European Gastroenterology Week (12/10/2024-15/10/2024, Vienna)-
dc.titleSodium-glucose cotransporter-2 inhibitors were associated with lower risk of colorectal cancer and adenoma than metformin in patients with type 2 diabetes mellitus.-
dc.typeConference_Paper-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats